These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12798977)

  • 1. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men.
    Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF
    Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
    Prochazka H; Sjögren M; Agren H
    J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
    Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
    Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
    Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
    Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenfluramine challenge, self-injurious behavior, and aggression in rhesus monkeys.
    Tiefenbacher S; Davenport MD; Novak MA; Pouliot AL; Meyer JS
    Physiol Behav; 2003 Nov; 80(2-3):327-31. PubMed ID: 14637232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking decreases the prolactin response to serotonergic stimulation in subgroups of alcoholics and controls.
    Anthenelli RM; Maxwell RA
    Alcohol Clin Exp Res; 2000 Jul; 24(7):987-95. PubMed ID: 10924001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine.
    Reist C; Mazzanti C; Vu R; Tran D; Goldman D
    Am J Med Genet; 2001 May; 105(4):363-8. PubMed ID: 11378851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects.
    Cleare AJ; Bond AJ
    Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia.
    Mohr P; Horácek J; Motlová L; Libiger J; Czobor P
    Schizophr Res; 1998 Feb; 30(1):91-9. PubMed ID: 9542792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study.
    Soloff PH; Lynch KG; Moss HB
    Alcohol Clin Exp Res; 2000 Nov; 24(11):1609-19. PubMed ID: 11104107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
    Young AH; Rue J; Odontiadis J; Cowen PJ
    Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
    Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
    Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
    Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M
    Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of d, l-fenfluramine and citalopram challenges in healthy adults.
    Flory JD; Manuck SB; Perel JM; Muldoon MF
    Psychopharmacology (Berl); 2004 Jul; 174(3):376-80. PubMed ID: 14997271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.
    Baumann MH; Ayestas MA; Rothman RB
    J Neurosci; 1998 Nov; 18(21):9069-77. PubMed ID: 9787010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin response to D-fenfluramine in outpatients with major depression.
    Kavoussi RJ; Kramer J; Hauger RL; Coccaro EF
    Psychiatry Res; 1998 Jul; 79(3):199-205. PubMed ID: 9704866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fenfluramine challenge on cocaine craving in addicted male users.
    Buydens-Branchey L; Branchey M; Hudson J; Rothman M; Fergeson P; McKernin C
    Am J Addict; 1998; 7(2):142-55. PubMed ID: 9598218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder.
    Soloff PH; Kelly TM; Strotmeyer SJ; Malone KM; Mann JJ
    Psychiatry Res; 2003 Jul; 119(1-2):11-24. PubMed ID: 12860356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.